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Detection in clinical specimens
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Legionella is a Gram-negative bacterium that can cause Pontiac fever, a mild upper 
respiratory infection and Legionnaire’s disease, a more severe illness. We aimed to com-
pare the performance of urine antigen, culture, and polymerase chain reaction (PCR) 
test methods and to determine if sputum is an acceptable alternative to the use of more 
invasive bronchoalveolar lavage (BAL). Data for this study included specimens tested for 
Legionella at Public Health Ontario Laboratories from 1st January, 2010 to 30th April, 
2014, as part of routine clinical testing. We found sensitivity of urinary antigen test (UAT) 
compared to culture to be 87%, specificity 94.7%, positive predictive value (PPV) 63.8%, 
and negative predictive value (NPV) 98.5%. Sensitivity of UAT compared to PCR was 
74.7%, specificity 98.3%, PPV 77.7%, and NPV 98.1%. Out of 146 patients who had a 
Legionella-positive result by PCR, only 66 (45.2%) also had a positive result by culture. 
Sensitivity for culture was the same using either sputum or BAL (13.6%); sensitivity for 
PCR was 10.3% for sputum and 12.8% for BAL. Both sputum and BAL yield similar 
results regardless testing methods (Fisher Exact p-values = 1.0, for each test). In sum-
mary, all test methods have inherent weaknesses in identifying Legionella; therefore, 
more than one testing method should be used. Obtaining a single specimen type from 
patients with pneumonia limits the ability to diagnose Legionella, particularly when urine 
is the specimen type submitted. Given ease of collection and similar sensitivity to BAL, 
clinicians are encouraged to submit sputum in addition to urine when BAL submission is 
not practical from patients being tested for Legionella.
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inTrODUcTiOn
Legionella is a Gram-negative, rod-shaped bacterium of the Legionellaceae family that exists 
ubiquitously in soil and water (1, 2). There are more than 50 Legionella species and 70 serogroups 
currently. Of all Legionella species, 21 species are believed to cause human disease (2). Legionella 
can cause two distinct clinical presentations: Pontiac fever (PF), a mild upper respiratory infection 
with non-specific influenza-like illness symptoms and Legionnaire’s disease (LD), which has a more 
severe clinical presentation including pneumonia (3). Both PF and LD are underdiagnosed; patients 
with PF have mild, self-limiting influenza-like symptoms that mimic those of other respiratory 
pathogens. Individuals with LD are often diagnosed with community-acquired pneumonia, treated 
empirically, and do not receive laboratory testing. In addition, because of ease of collection, clinicians 
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often use urine specimens to test for Legionella using commercial 
urinary antigen tests (UAT), most of which only detect Legionella 
pneumophila serogroup 1. Testing of urine for Legionella antigen 
has a reported sensitivity of 70–80% when compared to Legionella 
culture of respiratory specimens and does not allow for linkage of 
human isolates with Legionella-positive environmental samples, 
which is usually done using sequence-based typing (SBT) (4). 
In a recent Legionella study, more patients were confirmed for 
Legionella by UAT than culture or polymerase chain reaction 
(PCR); the authors hypothesized that the increased sensitivity 
compared to culture was because most cases were community 
acquired with less severe disease and the increased sensitiv-
ity over PCR was due to the predominance of L. pneumophila 
serogroup 1 (5).
Culture-based testing can help to identify links between envi-
ronmental sources and human isolates and has traditionally been 
considered as the gold standard for diagnosis of Legionella (2). In 
Ontario, the primary specimen type to undergo culture testing 
has historically been obtained through bronchoalveolar lavage 
(BAL), a procedure that is only used for a minority of patients 
tested for Legionella because of its invasive nature. Testing of 
sputum from the upper respiratory tract through culture-based 
methods is potentially a viable non-invasive alternative; however, 
reports from other studies have indicated variable sensitivity 
from less than 10 to 80%, and its use is often limited by the fact 
that many patients with LD do not produce sputum (6).
Public Health Ontario Laboratories (PHOL), which performs 
the majority of testing for Legionella in the province of Ontario, 
Canada has historically used UAT and/or culture of respiratory 
specimens, most commonly BAL specimens, in order to detect 
Legionella in patients with suspected infection due to this patho-
gen. PCR for detection of Legionella in clinical samples was intro-
duced at PHOL on 28th May, 2012, using a protocol developed at 
the Center for Disease Control and Prevention, USA (US CDC) 
(7). PCR is a sensitive and rapid test that can detect Legionella 
species from clinical and environmental sources. Similar to cul-
ture, PCR is able to detect all Legionella species and serogroups. 
Testing of specimens early during the course of disease and 
obtaining specimens from the lower respiratory tract has been 
reported to result in improved PCR sensitivity (8). Sensitivity of 
PCR compared to culture was reported to be 100% (9). In another 
study, PCR was reported to be better than culture at detecting 
less severe disease (10). When molecular typing is indicated, 
SBT can often be performed on primary L. pneumophila PCR-
positive specimens, which are culture-negative (based on PHOL 
experience). Avni et al. compared results of PCR in respiratory 
specimens with UAT results and reported a better sensitivity of 
PCR than UAT and similar specificity (11). PCR findings led to 
reclassification of 18% of LD symptomatic cases with previously 
negative UAT.
Comparing the performance of different test methods is chal-
lenging since there is an absence of a true gold standard method; 
the commonly used BinaxNOW® UAT only identifies L. pneu-
mophila serogroup 1 while culture has been reported to have 
a low sensitivity. In addition, PCR may result in false-positive 
results due to contamination of test reagents with Legionella 
DNA (12).
The purpose of our study was to describe Legionella testing at 
PHOL, to compare the performance of urine antigen, culture and 
PCR test methods, and to determine if sputum is a viable speci-
men alternative to the use of more invasive BAL for Legionella 
PCR and culture, especially for investigations when there is a 
need to link human isolates to environmental sources.
MaTerials anD MeThODs
Data for this study included specimens tested for Legionella at 
PHOL from 1st January, 2010 to 30th April, 2014. Specimens 
included in this study were tested as part of routine clinical testing.
Test Methods
PHOL tested urine specimens for L. pneumophila serogroup 1 
using Alere BinaxNOW® Legionella Urinary Antigen Card (MA, 
USA), and all appropriate specimens such as aspirate, BAL, lung 
tissue, sputum, nasopharyngeal swab, pleural fluid, etc., were 
tested for Legionella by culture until 28th May, 2012. After this 
date, PHOL implemented PCR testing for Legionella on respira-
tory specimens, and culture was only used on specimens testing 
positive by PCR for the purpose of facilitating molecular typing 
by SBT when indicated.
Culture-based testing for Legionella was performed using 
buffered charcoal yeast extract-based agar (BCYE) and buffered 
polymyxine B, anisomycin, and vancomycin (BPAV) charcoal 
media. The plates were re-incubated at 35°C for up to 14  days 
and examined under a microscope daily for colonial morphology 
such as a mottled surface and iridescent red–blue–green sheen 
or a faceted cut-glass appearance. Legionella growth was visible 
only after at least 3 days of incubation. All non-urine specimens 
tested for the presence of Legionella DNA were examined using 
real-time PCR with primers and probes as described in US CDC’s 
published methodology (7). The PCR has two probes, one for all 
Legionella species, and one for L. pneumophila. Primers target-
ing the 23S-5S rRNA intergenetic spacer region conserved for 
all Legionella species were used, as previously published by US 
CDC (7). The forward and reverse primers were 5′-GTA CTA 
ATT GGC TGA TTG TCT TGA CC-3′ and 5′-CCT GGC GAT 
GAC CTA CTT TCG-3′, respectively. Two probes were designed 
within the amplicon region. One is specific for L. pneumophila 
(5′-Cal Flour Orange 560-ATC GTG TAA ACT CTG ACT CTT 
TAC CAA ACC TGT GG-3′BHQ), the other one recognizes all 
known Legionella species (5′-FAM ATC TC“G” AA“C” T“C”A 
“G”AA “G”T“G” AAA C-3′BHQ) (“” denotes locked nucleic 
acid), and is referred to as the genus-wide probe or Legionella 
spp. probe.
Slide agglutination testing (SAT) was used to speciate and 
serogroup L. pneumophila isolates and atypical Legionella-like 
isolates. Known antibodies were mixed with culture isolates on a 
glass microscope slide. Antibodies against 50 Legionella species/
serogroup targets were used for this method based on the protocol 
developed by US CDC (13). Agglutination reactions were scored 
on a scale from 4 + (strongest) to 1 + (barely visible). In cases of 
cross-reaction (two or more species/serogroup targets reactive), 
results were compared against specific positive and negative 
controls. The strongest reaction was considered the final result.
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Data Transformation
First, the data were converted from the test to specimen level as 
more than one test may have been performed per specimen. In 
the event of discrepant results between different test methods, 
a positive result took precedence over an indeterminate or a 
negative result. In the event of more than one positive result 
for a single specimen, the result that reflected a more detailed 
level of identification was considered the final outcome; for 
example serogroup took precedence over species. Second, the 
data were transformed from the specimen to patient level, as 
more than one specimen may have been tested per patient. 
Patients were identified based on their health card number 
or first name, last name, and date of birth if the health card 
number information was missing. Third, separate patient 
episodes were identified as some patients were tested for 
Legionella more than once a year or during the study period; we 
determined each unique episode to span 90 days from the time 
the first specimen was received. Specimens were considered 
to be part of a single episode if the period between the first 
and subsequent specimen submission dates was ≤90  days. 
The time was reset for the next consecutive 90-day timeframe 
for specimens from the same patient received after 90  days. 
When there was more than one discrepant result per patient 
episode, a final result was assigned for each patient with a 
positive result taking precedence over an indeterminate or 
a negative result. In addition, a Legionella-positive specimen 
identified to a more detailed level took precedence over any 
other Legionella-positive specimens, and the earliest date was 
used to identify that episode.
Another transformation was done at the test level to compare 
the performance of different specimen types and Legionella test 
methods. For both comparisons specimens submitted from 
the same patient episode within a 14 day lagging period from 
receipt of the first specimen were selected to avoid bias related 
to delays in specimen submission. For those patients for whom 
both sputum and BAL specimens were submitted, test results for 
each source were compared. Indeterminate results were excluded 
from these analyses.
For the purpose of this study, cases refer to individuals who 
tested positive for Legionella during a single episode, and con-
trols are individuals who tested negative during a single episode. 
Patients refer to both cases and controls being tested for Legionella 
infection.
Data analyses
Statistical analyses were performed at the patient and specimen 
level using Stata/SE version 10.0 (StataCorp LP, College Station, 
TX, USA). Data for this study were analyzed two ways: by patient 
episode and by test method. Patient episode data were used to 
describe the patients’ demographic characteristics and to describe 
the seasonality of Legionella including trends. Data for 2014 were 
not complete and thus were not considered for the trend analysis. 
Chi-square test was used to compare demographic information 
between patients.
Specimen source and test method comparisons were per-
formed at the test level. Sensitivity and specificity were reported, 
including 95% confidence intervals. Chi-square was used to 
compare sensitivity and specificity of test methods during 
 different episodes. Fisher’s exact test was used in the event of a 
sample size less than five.
ethics
These data are also used for routine laboratory surveillance, which 
is a mandate of Public Health Ontario. Therefore, consultation 
with our organization’s privacy office or ethics committee was not 
required. To protect patient privacy and confidentiality, data are 
reported in an aggregated anonymized format.
resUlTs
During the study period, 28,965 patients were tested for Legionella. 
UAT was the main test method and was used for 23,389 (81%) 
patients. Culture-based testing was used for 3,832 (13%) patients 
and PCR for 3,661 (13%) patients. Legionella was detected by 
any test method in 725 (2.5%) patients. Percent positivity for 
UAT was 2.8% (649/23,389 patients tested), for culture was 2.8% 
(109/3,832), and for PCR was 3% (108/3,661). These results are 
not mutually exclusive because 2,083 (7.2%) patients were tested 
by more than one method, with UAT and PCR being the most 
common co-test methods, used in 1,048/28,965 (3.6%) patients. 
Since its implementation, PCR was used to diagnose Legionella 
among 23% of the patients. Peak detections occurred in July in 
2010 and 2013 (6.1 and 7.7% of all patients tested for Legionella 
during that month, respectively) and in August in 2011 and 2012 
(8.2 and 9.7%, respectively) (Figure 1).
Patient characteristics
The mean age of patients tested for Legionella was 63 years, with a 
range of 2 days to 102 years. There was a statistically significant dif-
ference in age between individuals testing positive for Legionella 
(cases) and those testing negative (controls) (p-value <  0.001). 
Compared to controls, cases were more likely to be in the 40 to 
69 year age group. The age group with the highest proportion of 
individuals testing positive for Legionella (4.3%) was the 50 to 
59 year group (Figure 2). Of patients tested for Legionella, 15,625 
(54.4%) were males. Five hundred and five cases (69.9%) were 
males compared with 15,120 (54.1%) controls. Cases were more 
likely than controls to be males (p-value < 0.001).
Testing characteristics
A range of 1–17 specimens were submitted per patient for 
Legionella testing during the study period; 27,561 (95.2%) 
patients had specimens submitted for a single episode, and 22,105 
(76%) patients had only one specimen submitted. Of patients 
with specimens submitted for multiple episodes, none tested 
positive for Legionella for more than a single episode. The maxi-
mum number of episodes for which any patient had specimens 
submitted was six, and these were related to a single patient who 
was immunocompromised. Legionella was not identified in any 
specimens tested from this patient.
Of the patients who had more than one Legionella-positive 
specimen (n = 149), the mean number of days that any patient 
remained Legionella-positive was 5.1  days with a range of 
0–67 days and SD of 11.8 days. Of all cases, 576 (79.5%) had only 
FigUre 2 | number of Legionella cases, and precent of patients  test-positive, by age group, PhOl, 1st January, 2010 to 30th april, 2014.
FigUre 1 | Patient percent positivity for Legionella by month, PhOl, 1st January, 2010 to 31st December, 2013£*.
4
Peci et al. Comparison of  Legionella Testing Methods
Frontiers in Public Health | www.frontiersin.org August 2016 | Volume 4 | Article 175
specimen and tested positive by UAT until 67 days after the first 
positive test result.
Legionella serogroups
Of all Legionella species identified during our study, 700 (96.6%) 
were L. pneumophila, and 25 (3.4%) were L. non-pneumophila. 
L. pneumophila serogroup 1 represented 680 (93.8%) of all 
one positive specimen. One patient tested positive for Legionella 
for 67 days. This patient had nine specimens tested out of which 
eight were positive for L. pneumophila serogroup 1. This also 
represented the highest number of positive specimens for any 
patient. Specimen sources submitted from this patient included 
urine, sputum, and BAL; the patient continued to test positive by 
culture and PCR for 45 days from the time of the first positive 
TaBle 1 | Legionella species and serogroups identified among 725 
Legionella cases by PhOl, January 2010 to april 2014.
Legionella species Legionella serogroup (sg) counts Percentage
L. pneumophila L. pneumophila not 
serotypeda
15 2.1
L. pneumophila sg1b 680 93.8
L. pneumophila sg2 1 0.1
L. pneumophila sg3 2 0.3
L. pneumophila sg6 1 0.1
L. pneumophila sg9 1 0.1
Subtotal of L. pneumophila 700 96.6
L. non-pneumophila L. longbeachae1 1 0.1
L. maceachernii 1 0.1
L. micdadei 2 0.3
L. non-pneumophila not 
serotyped
21 2.9
Subtotal of L. non-pneumophila 25 3.4
Overall 725 100.0
aNot serotyped meaning that Legionella pneumophila was identified by PCR alone 
(n = 13), or an attempt to serotype was made but the serotype could not be 
determined (n = 2).
bThe majority (523; 72.4%) of patients with L. pneumophila sg1 infection were tested 
by UAT only.
sg, serogroup.
TaBle 3 | comparison of performance indicators for Legionella UaT, 
culture and Pcr, PhOl, January 1, 2010 to april 30, 2014£.
Performance  
indicators
Binax vs.  
culture
Binax vs.  
Pcr
culture vs. 
Pcr
TP/(TP + FN) Sensitivity 87.0 (76.9–93.2) 74.7 (63.1–83.7) 45.2 (37–53)
TN/(TN + FP) Specificity 94.7 (76.9–93.2) 98.3 (97.2–99.0) NA
TP/(TP + FP) PPV 63.8 (53.7–72.7) 77.7 (66.1–86.3) NA
TN/(TN + FN) NPV 98.5 (97.2–99.2) 98.1 (96.9–98.7) NA
TP, true positive; TN, true negative; FN, false-negative; FP, false-positive; NA, not 
applicable.
TaBle 2 | comparing Legionella test methods, PhOl 1st January, 2010 
to 30th april, 2014.
culture Pcra
Binax Positive negative Total Positive negative Total 
Positive 67 38 105 56 16 72
Negative 10 680 690 19 961 980
Total 77 718 795 75 977 1,052
aFour patients with indeterminate results by PCR were excluded from the analyses.
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Legionella identified to the species or higher level by PHOL; all 
Legionella species identified at PHOL are documented in Table 1.
Test Method comparison
When comparing UAT to culture, Legionella culture was 
considered the gold standard as it can detect all Legionella spe-
cies. Overall, 795 patients were tested by UAT and Legionella 
culture during the same episode (Table 2). Of these, 67 (8.4%) 
patients were Legionella-positive by both UAT and culture. Ten 
patients had a positive Legionella result by culture alone and 38 
patients by UAT alone. Sensitivity of UAT compared to culture 
was 87%, specificity was 94.7%, positive predictive value (PPV) 
was 63.8%, and negative predictive value (NPV) was 98.5% 
(Table  3). Legionella was not detected by UAT in 10 (12%) 
patients for whom culture was positive. Of these 10 patients, 6 
were Legionella culture-positive for L. pneumophila serogroup 
1 and the other patients were positive for L. pneumophila sero-
group 6 (n =  1), L. micdadei (n =  1), L. longbeachae (n =  1), 
and L. maceachernii (n = 1). Conversely, culture did not detect 
L. pneumophila serogroup 1 in 38 (36%) patients for whom UAT 
had a positive test result. The overall estimates for UAT were 
compared to culture only for the period before implementation 
of PCR. All estimates were not significantly different except 
specificity of UAT, which was slightly higher prior to the 
 implementation of PCR (97.7 vs. 94.7%, p-value < 0.05).
Comparing Legionella UAT to PCR, we considered PCR to be 
the reference test based on previously published results as well 
as its greater ability to detect all Legionella species (11). Overall, 
there were 1,052 patients who had both UAT and PCR performed 
(Table 2). Fifty-six specimens were positive for Legionella species 
by both UAT and PCR, 19 patients were positive by PCR alone, 
and 16 patients were positive by UAT alone. UAT did not identify 
Legionella for 19 (25%) patients for whom PCR had a positive 
result. Of these 19 patients, L. pneumophila was detected in 9 
patients and L.  non-pneumophila was detected in 10. Of those 
with L. pneumophila, three had results confirmed by culture 
for L.  pneumophila serogroup 1 (n =  2) and L. pneumophila 
serogroup 6 (n =  1); the rest did not have serogroup testing 
performed. Conversely, 16 (22.2%) patients in whom L.  pneu-
mophila serogroup 1 was confirmed by UAT were negative by 
PCR. Sensitivity of UAT compared to PCR was 74.7%, specificity 
was 98.3%, PPV was 77.7%, and NPV was 98.1% (Table 3).
We were unable to fully compare and report all parameters 
for culture and PCR since subsequent to 28th May, 2012, culture 
was only used for patients testing positive for Legionella by PCR. 
Of 146 patients who had a Legionella-positive result by PCR, 
only 66 (45.2%) also had a positive result by culture (Table 3). 
Specimens from 80 patients did not grow in culture, and of these, 
23 were identified by PCR as L. non-pneumophila, and 57 were 
L. pneumophila not serotyped.
specimen source comparison
Percent positivity of sputum and BAL were compared to under-
stand the utility of sputum as an appropriate specimen source to 
detect Legionella. Out of 625 sputum specimens tested, 64 (10.2%) 
were positive for Legionella. Out of 9,275 BAL specimens tested, 
215 (2.3%) were positive for Legionella. Overall, percent positivity 
in sputum was higher compared to BAL (p-value < 0.05). When 
we compared sputum and BAL by test method, 30/297 (10.1%) 
sputum specimens and 106/4,697 (2.3%) BAL specimens were 
positive for Legionella by culture. Testing by Legionella PCR 
identified Legionella in 34/326 (10.4%) sputum specimens 
and in 109/4,568 (2.4%) BAL specimens. Percent positivity for 
Legionella was higher in sputum as opposed to BAL regard-
less of test method (p-value <  0.05). Culture results were then 
analyzed only for the period prior to implementation of PCR 
since, subsequent to its introduction, culture was only used for 
PCR-positive specimens. Percent positivity was reduced for both 
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sputum and BAL;  specifically of 254 sputum specimens tested by 
Legionella culture before 28th May, 2012, 9 (3.5%) were positive 
for Legionella, and out of 4,447 BAL specimens tested by culture, 
55 (1.2%) were positive for Legionella. Positivity was higher in 
sputum as opposed to BAL; however, the difference was smaller 
when compared with the entire study period.
Further, we compared test results of sputum and BAL con-
trolling for test method and patient episode. For this analysis, we 
compared only those specimens that were tested from the same 
patient within the same episode and within a 14-day lag period. 
This time frame was selected to avoid bias related to delays in 
testing, which may affect results. Twenty-two patients had both 
sputum and BAL specimens tested by culture and 39 patients had 
sputum and BAL tested by PCR. Sensitivity for culture was the 
same using either sputum or BAL (13.6%) as the source (Fisher 
Exact p-value = 1.0). Sensitivity for PCR was 10.3% for sputum 
and 12.8% for BAL; results were not significantly different 
(Fisher Exact p-value = 1.0). When we checked culture results 
just for the period prior to introduction of PCR, sensitivity of 
sputum vs. BAL were not significantly different (Fisher Exact 
p-value = 1.0).
In addition to sputum and BAL, Legionella was also identified 
in 2/44 (4.5%) aspirate (exact source not documented on test 
requisition), 2/78 (2.6%) pleural fluid, and 3/185 (1.6%) speci-
mens with an unspecified source. Legionella was not identified 
in autopsy (n = 15), blood (n = 2), lung tissue (n = 361), naso-
pharyngeal swab (n = 22), or tracheal tissue specimens (n = 18).
DiscUssiOn
In this study, we describe Legionella testing at PHOL. Legionella 
was identified in approximately 3% of patients and percent 
positivity for each test method (UAT or culture or PCR) was also 
approximately 3%. As reported elsewhere, Legionella detection 
peaked in late summer (14) with Legionella most commonly 
identified in older males (4). Seventy-six percent of patients 
tested for Legionella species had only one specimen submitted 
and almost 70% of the patients were tested by UAT alone. As 
reported previously, L. pneumophila serogroup 1 was the most 
common serotype identified in Ontario (1); less than 4% of 
positive Legionella results were L. non-pneumophila. However, 
we may have overestimated the prevalence of L. pneumophila 
serogroup 1 as UAT alone was the predominant testing method 
used at PHOL, because many patients only have urine specimens 
submitted for Legionella testing.
A higher number of BAL than sputum specimens were sub-
mitted at PHOL for Legionella testing. Historically, BAL has been 
considered to be the optimal respiratory specimen for identifica-
tion of Legionella, likely because less than one-half of patients 
infected with Legionella produce sputum (2). Percent positivity in 
sputum was higher than BAL for both culture and PCR. However, 
when we compared the performance of the two sources, control-
ling for patient episode (i.e., same patient and within the same 
episode), positivity of sputum and BAL were not significantly 
different (Fisher exact p-value = 1). This finding contrasts results 
of a previous study in which positivity of culture results were 
reported to be higher for BAL than sputum (15); however, that 
study had a very small number of patients and sputum, and BAL 
were not collected from the same patient within the same disease 
episode. In a systematic review, subgroup analysis by specimen 
type found similar sensitivity and specificity for sputum and BAL 
specimens tested by PCR (11).
A key added benefit to the use of sputum is that a sample 
can easily be obtained from patients, and it is a non-invasive 
procedure.
When comparing UAT to culture, UAT demonstrated high 
sensitivity (87%) and very high specificity (97.7%). Binax detected 
L. pneumophila serogroup 1 in 38 patients for whom culture had a 
negative result. This may reflect that culture has a lower reported 
sensitivity (10). However, some of the positive results by UAT 
alone may indicate false-positive results. False-positive results by 
urine antigenic testing have been reported previously and have 
been attributed to serum sickness or the presence of rheumatoid 
factor (16). Testing by Legionella PCR could have differentiated 
this; however, we were unable to perform further testing due to 
the retrospective nature of this study.
In addition, UAT indicated a negative test result for 10 speci-
mens, which culture reported as Legionella positive. The inability 
of UAT to detect species/serogroups other than L. pneumophila 
serogroup1 may explain part of the discrepancy. However, when 
we investigated the reasons for discordance, only 6 out of 10 were 
identified as L. pneumophila serogroup 1 species. False negative 
results by UAT might be due to the critical need of immediate 
testing of urine specimens as prolonged time prior to testing may 
result in the degrading of urine antigen (17). In addition, false 
negative UAT results may be related to lower sensitivity of UAT 
in milder Legionella infections or to the need for higher concen-
tration of urine samples when performing UAT (18). At PHOL, 
we do not routinely concentrate urine specimens before testing. 
Specificity of UAT in comparison to culture dropped after PCR 
introduction. This was due to the fact that culture was used only 
on PCR-positive specimens – a subset of patients who had true 
Legionella infection were missed by culture but were picked up by 
UAT, falsely decreasing the specificity of urine when using culture 
as the reference method. The same factor contributed to the poor 
PPV (63.8%) for UAT.
When comparing Legionella UAT to PCR, considering PCR as 
the reference method, UAT demonstrated a moderate sensitiv-
ity (74.7%) and very high specificity (98.3%). UAT detected 16 
L.  pneumophlia serogroup 1 positive specimens that were not 
detected by PCR. This may be attributed to false-positive UAT 
results (explained above) or false-negative PCR results due to 
PCR inhibition, primer and/or probe mismatch, the presence 
of Legionella target in quantities below the limit of detection or 
improper specimen collection and handling (19). UAT did not 
detect 19 Legionella-positive specimens detected by PCR and half 
of them were L. pneumophila serogroup 1. While false-positive 
PCR results may occur as a result of specimen contamination 
with Acinetobacter spp. or Gemella spp. (18), it is more likely that 
the discordant result was the result of higher PCR sensitivity. 
At PHOL, we also identified that Legionella PCR gave a false-
positive result in at least three patients due to cross-reaction with 
Stenotrophomonas maltophilia by the Legionella species target 
but not the L. pneumophila.
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Legionella culture results could not be compared to PCR 
results due to the change in testing algorithm, whereby culture 
was only set up if respiratory specimens were PCR-positive. 
However, of all specimens positive for Legionella by PCR, only 
45% were successfully grown in culture. Sensitivity of culture 
compared with PCR (45%) was much lower than the sensitivity 
of UAT to PCR (74.7%). The low sensitivity, longer turnaround 
time, and technical expertise required to isolate Legionella spp. 
in culture resulted in culture not being the method of choice 
for detecting Legionella (20). However, culture is still useful for 
isolating the bacteria to facilitate the linkage between clinical to 
environmental specimens by molecular typing, usually SBT.
Finally, we were able to report on prolonged Legionella detec-
tion from a single patient. The patient tested positive for 67 days 
after the first positive specimen, with the last positive specimen 
source being urine, tested by UAT. We were able to do so because 
the patient had nine specimens submitted for testing. Detection 
of Legionella antigen in the urine has been reported for as long 
as 300  days (21). Prolonged detection from urine complicates 
interpretation of positive results with respect to the timing of 
antibiotic treatment.
This study has some limitations. Legionella cases reported 
here may not represent all Legionella cases in Ontario for two 
main reasons: many cases with PF are not detected and thus 
not reported (22). In addition, the Alere Binax UAT is not 
approved for testing PF patients, and its test characteristics in 
PF have not been well characterized. As well, patients tested by 
UAT who are infected with species other than L. pneumophila 
serogroup 1 will have unrecognized infection. Test methods 
were not used consistently during the study period, which 
prevented us from conducting a comprehensive comparison 
between different test methods. The change in testing algo-
rithm after implementation of PCR prevented us from being 
able to compare culture and PCR test methods, as culture was 
only performed on PCR-positive specimens post PCR imple-
mentation, for the purpose of facilitating molecular typing 
by SBT when indicated. It also prevented us from comparing 
UAT, culture, and PCR results among all patients who were 
tested by all three methods.
Since clinical information was not reported consistently on 
laboratory requisitions, we could not clinically describe patients 
from whom specimens were collected or comment on their dis-
ease severity or trajectory. Last, comprehensive testing to deter-
mine the cause of clinical illness may result in an unrepresentative 
sample or sampling biases, with sicker patients more likely to be 
tested for Legionella using multiple test methods.
cOnclUsiOn
In summary, all test methods have inherent weaknesses for 
the identification of Legionella; therefore, more than one test-
ing method should be used. Obtaining a single specimen type 
from patients with pneumonia limits the ability to diagnose 
Legionella, particularly when urine is the specimen type submit-
ted. Additionally, detection of Legionella using urine alone does 
not facilitate identification of linkages between clinical isolates 
and potential environmental exposures, which is achieved by 
molecular typing, specifically SBT. Given ease of collection, and 
its similar sensitivity to BAL, clinicians are encouraged to submit 
sputum in addition to urine when BAL submission is not practi-
cal, from patients being tested for Legionella.
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